Amino Acid-Nitrate Compositions for Vasodilation and Bioavailability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional amino acids, nitrates, and nitrites have limitations in terms of bioavailability, solubility, and effectiveness in achieving vasodilation and bioabsorption, requiring high doses and long metabolism times, and are prone to tolerance development.

Innovation Solution

Amino acid compositions combining specific amino acids like Arginine, Citrulline, Creatine, Glutamine, and others with nitrates or nitrites, enhancing water solubility and bioabsorption, and providing faster vasodilation effects through nitric oxide production, while preventing tolerance development.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional amino acids, nitrates, and nitrites are used alone, then the formulation is simple, but bioavailability and solubility are limited requiring high doses

Engineering Contradiction:
Improvedose requirementVSAvoidbioavailability
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent combines amino acids (such as arginine, citrulline, creatine, glutamine, lysine, ornithine, proline, or valine) with nitrates or nitrites in specific formulations. This merging creates a synergistic effect where the amino acid component enhances the solubility and bioavailability of the nitrate/nitrite, allowing lower doses to achieve the same therapeutic effect while improving nitrogen oxide production and vasodilation efficiency.

Inventive Principle:
Principle #5Merging (Combining)

2Reliability

If conventional nitrates and nitrites are used, then the formulation is straightforward, but vasodilation effectiveness is reduced and tolerance develops

Engineering Contradiction:
Improvevasodilation effectivenessVSAvoidtolerance development time
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent modifies the chemical and physiological parameters by combining nitrates/nitrites with specific amino acids that have complementary metabolic pathways. The amino acids serve as precursors or cofactors that enhance nitric oxide synthesis, thereby improving vasodilation effectiveness. Additionally, this parameter change prevents tolerance development by providing alternative metabolic routes and sustaining nitrogen oxide production over time.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If high doses of conventional nitrates are administered, then vasodilation effect is achieved, but tolerance develops rapidly

Engineering Contradiction:
Improvevasodilation effectVSAvoidtolerance resistance
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent employs preliminary action by including amino acids that serve as precursors for nitric oxide synthesis alongside nitrates or nitrites. These amino acids (such as arginine, citrulline, or ornithine) are metabolized to produce nitric oxide through alternative pathways, ensuring sustained vasodilation effectiveness. This preliminary preparation of multiple metabolic routes prevents tolerance development by maintaining nitrogen oxide production without requiring increasing doses.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The amino acid-nitrate/nitrite compositions improve bioavailability, reduce required doses, enhance vasodilation and muscle distribution, and prevent nitrate tolerance, offering sustained nitric oxide production and improved athletic performance.

Implementation Method 1

providing faster vasodilation effects through nitric oxide production

Methodology Applied
Scientific EffectNitric oxide production: Chemical Bonding

Data Source

PatentUS8455531B2Amino acid compositions
Publication Date: 2013.06.04 THERMOLIFE INTERNATIONAL LLC
  • US8455531B2 patent drawing
  • US8455531B2 patent drawing
  • US8455531B2 patent drawing

AI summary

An amino acid composition is disclosed. The composition includes: at least one constituent selected from the group consisting of a nitrate, a nitrite, and both; and at least one constituent amino acid selected from the group consisting of Arginine, Agmatine, Beta Alanine, Citrulline, Creatine, Glutamine, L-Histidine, Isoleucine, Leucine, Norvaline, Ornithine, Valine, Aspartic Acid, Cysteine, Glycine, Lysine, Methionine, Proline, Tyrosine, and Phenylalanine. Also disclosed are a method for increasing the bioabsorption of Amino Acids in a human or animal and a method for increasing vasodilative characteristics of Amino Acids in a human or animal.